Revenue: The sum of all revenue fields included for a company's operating activities.
Clarus Therapeutics Holdings, Inc. (CRXTQ) had Revenue of $4.05M for the most recently reported fiscal quarter, ending 2022-06-30.
| Income Statement Financials | |
|
Revenue |
$4.05M |
$-10.69M |
|
$1.16M |
|
$2.89M |
|
$14.70M |
|
$-10.65M |
|
$-0.04M |
|
$-10.69M |
|
$-10.69M |
|
$-10.69M |
|
$-10.69M |
|
$-10.69M |
|
$-10.69M |
|
$-10.65M |
|
$-10.64M |
|
44.23M |
|
44.23M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$48.88M |
|
$0.06M |
|
$0.06M |
|
$48.94M |
|
$61.81M |
|
-- |
|
$0.20M |
|
$62.00M |
|
$-13.06M |
|
$-13.06M |
|
$-13.06M |
|
52.02M |
|
| Cash Flow Statement Financials | |
$-34.77M |
|
$-0.01M |
|
$27.54M |
|
$26.41M |
|
$19.17M |
|
$-7.24M |
|
$0.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.79 |
|
-- |
|
-- |
|
-- |
|
-3.10 |
|
71.36% |
|
-263.01% |
|
-263.01% |
|
-- |
|
-264.05% |
|
-264.05% |
|
$-34.78M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.07 |
|
0.47 |
|
193.44 |
|
81.86% |
|
81.86% |
|
-21.85% |
|
81.86% |
|
$-0.25 |
|
$-0.79 |
|
$-0.79 |
|